ANI Pharmaceuticals develops, manufactures, and commercializes innovative therapeutics for patients with rare diseases and chronic conditions. The company focuses on three core business segments: Rare Disease products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology; a Generics business leveraging U.S.-based manufacturing; and Established Brands serving ongoing patient needs. People drive ANI's mission of serving patients and improving lives. The company combines clinical precision with operational excellence, maintaining pharmaceutical manufacturing facilities in Minnesota and New Jersey while building teams across the United States to deliver sustainable growth and quality therapeutics.
970
Team Members
2001
Founded
Pharma
Sector
Hybrid
Work Environment
A world where patients with rare diseases and chronic conditions have access to the innovative, high-quality therapeutics they need to improve their lives.
At ANI Pharmaceuticals, our mission is to serve patients and improve lives by developing, manufacturing, and commercializing innovative and high-quality therapeutics.